Abstract
Purpose. To investigate the transport of α-tocopherol (T), tocopherol succinate (TS) and tocopherol succinate-3-glucose (a newly synthetized, less hydrophobic T ester; TSG) through bovine erythrocyte membranes.
Methods. Our experiments were carried out on erythrocytes (obtained from heparinized fresh bovine blood), because they represent a suitable model for investigations of membrane transport.
Results. T was shown to reside almost completely in the suspension medium, while the greater part of TS disappeared from the suspension medium and was mainly incorporated into erythrocyte membranes. In comparison with T, a larger amount of TSG was incorporated into erythrocyte membranes and taken up by cells; however the TSG intra-cellular accumulation was significantly lower than that observed with TS. Furthermore, the transport of TS and TSG was partially inhibited by p-chloromercuribenzenesulfonate (which inhibits monocarboxylate uptake; PCMBS) and by maltose (a competitive inhibitor of glucose transport) respectively, with a concomitant increase in drug membrane incorporation. No significant change in drug transport was observed in the presence of 4,4′-diisothiocyanostilbene-2,2′-disulfonate, a selective and irreversible blocker of band 3 protein (DIDS).
Conclusions. Our results show 1) the existence of large differences in membrane incorporation of T, TS and TSG (very likely caused by differing abilities to fill spaces in the lipid bilayer) and 2) a specific contribution of the monocarboxylate transport protein and of the glucose transport protein in the cellular uptake of TS and TSG, respectively. A tempting suggestion is that the unique cytoprotective properties of TS may be related to the differences in the transmembrane mobility observed between T and its succinate ester. Furthermore, T conjugation to a monocarboxylate or glycoside moiety could provide suitable substrates for active membrane transport, thus appearing as a promising pharmaceutical strategy for the improved delivery of tocopherol derivatives.
Similar content being viewed by others
REFERENCES
S. A. B. E. van Acker, L. M. H. Koymans, and A. Bast. Molecular pharmacology of vitamin E: structural aspects of antioxidant activity. Free Rad. Biol. Med. 15:311–328 (1993).
V. E. Kagan, E. A. Serbinova, R. A. Bakalova, Ts. S. Stoytchev, A. N. Erin, L. L. Prilipko, and R. P. Evstigneeva. Mechanism of stabilization of biomembranes by alpha-tocopherol. The role of the hydrocarbon chain in the inhibition of lipid peroxidation. Biochem. Pharmacol. 40:2403–2413 (1990).
E. Serbinova, V. Kagan, D. Han, and L. Packer. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Rad. Biol. Med. 10:263–275 (1991).
M. W. Fariss. Oxygen toxicity: unique cytoprotective properties of vitamin E succinate in hepatocytes. Free Rad. Biol. Med. 9:333–343 (1990).
A. Saija, M. Scalese, M. Lanza, D. Marzullo, F. Bonina, and F. Castelli. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Rad. Biol. Med. 19:481–6 (1995).
Y. Matsumoto, and M. Ohsako. Transport of drugs through human erythrocyte membranes: pH dependence of drug transport through labeled human erythrocytes in the presence of band 3 protein inhibitor. J. Pharm. Sci. 81:428–31 (1992).
Y. Matsumoto, M. Ohsako, A. Takadate, and S. Goto. Reduction of erythrocyte membrane permeability and protein binding of low-molecular-weight drugs following glycoside derivatization. J. Pharm. Sci. 82:399–403 (1993).
M. Mosior, W. A. Bialas, and J. Gomulkiewicz. Effect of DIDS on osmotic properties of bovine erythrocytes. Biochim. Biophys. Acta 945:51–5 (1988).
S. U. Devaskar. The mammalian brain glucose transport system. In M.K. Raizada, and D. LeRoith (eds.), Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. Plenum-Press, New York, 1991, pp. 405–417.
R. C. Poole, and A. P. Halestrap. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol. 264(Cell Physiol. 33):C761–C782 (1993).
A. Namane, C. Gouyette, M. Fillion, G. Fillion, and T. Huynh-Dinh. Improved brain delivery of AZT using a glycosyl phosphotriester prodrug. J. Med. Chem. 35:3039–3044 (1992).
J. Neuman, M. Hervé, J. Debouzy, F. I. Guerra, C. Gouyette, B. Dupraz, and T. Huynh-Dinh. Synthesis and transmembrane transport studies by NMR of a glucosyl phospholipid of thymidine. J. Am. Chem. Soc. 111:4270–4277 (1989).
I. Walker, D. Nicholls, W. J. Irwin, and S. Freeman. Drug delivery via active transport at the blood-brain barrier: affinity of a prodrug of phosphonoformate for the large amino acid transporter. Int. J. Pharm. 104:157–167 (1994).
T. Mizuma, K. Ohta, M. Hayashi, and S. Awazu. Intestinal active absorption of sugar-conjugated compounds by glucose transport system: implication of improvement of poorly absorbable drugs. Biochem. Pharmacol. 43:2037–2039 (1992).
T. Mizuma, K. Ohta, M. Hayashi, and S. Awazu. Comparative study of active absorption by the intestine and disposition of anomers of sugar-conjugated compounds. Biochem. Pharmacol. 45:1520–1523 (1993).
A. Carruthers, and A. L. Helgerson. Inhibitions of sugar transport produced by ligands binding at opposite sides of the membrane. Evidence for simultaneous occupation of the carrier by maltose and cytochalasin B. Biochem. 30:3907–15 (1991).
A. Hassner, and V. Alexanian. Direct room temperature esterI fication of carboxylic acids. Tetrahedron Lett. 46:4475–8 (1978).
G. Herrera, J. F. B. Vazquez, N. B. Iborra, and M. B. Riego Martin. Tensioactividad de productos derivados de grasas e hidratos de carbono. III. 3(6)-O-decanoil(lauroil)-D-glucosas. Grasas y Aceites 38:116–119 (1987).
M. W. Fariss, M. H. Merson, and T. M. O'Hara. Alpha-Tocopheryl succinate protects hepatocytes from chemical-induced toxicity under physiological calcium conditions. Toxicol. Lett. 47:61–75 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonina, F., Lanza, M., Montenegro, L. et al. Transport of Alpha-Tocopherol and Its Derivatives Through Erythrocyte Membranes. Pharm Res 13, 1343–1347 (1996). https://doi.org/10.1023/A:1016017832146
Issue Date:
DOI: https://doi.org/10.1023/A:1016017832146